Antigen presentation by murine dendritic cells is nuclear factor-kappa B dependent both in vitro and in vivo.

Antigen presentation by murine dendritic cells is nuclear factor-kappa B dependent both in vitro and in vivo.

Antigen presentation is a key rate-limiting step in the immune response. Dendritic cells (DCs) have been reported to be the most potent antigen-presenting cells for naïve T cells, but little is known about the biochemical pathways that regulate this function. We here demonstrate that mature murine D...

Full description

Bibliographic Details
Main Authors:	Yoshimura, S, Bondeson, J, Brennan, F, Foxwell, B, Feldmann, M
Format:	Journal article
Language:	English
Published:	2003

Similar Items

Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines.
by: Yoshimura, S, et al.
Published: (2001)

Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI.
by: Yoshimura, S, et al.
Published: (2001)

Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB.
by: Calder, V, et al.
Published: (2003)

Effective adenoviral transfer of IkappaBalpha into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines is nuclear factor-kappaB dependent.
by: Bondeson, J, et al.
Published: (2000)

Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators.
by: Bondeson, J, et al.
Published: (1999)

Selective regulation of cytokine induction by adenoviral gene transfer of IkappaBalpha into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappaB independent.
by: Bondeson, J, et al.
Published: (1999)

Ikappa B kinase 2 but not NF-kappa B-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction.
by: Andreakos, E, et al.
Published: (2003)

Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent.
by: Foxwell, B, et al.
Published: (1998)

High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approach.
by: Foxwell, B, et al.
Published: (2001)

Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?
by: Feldmann, M, et al.
Published: (2002)

Improved immune recognition through antigen targeting to the mannose receptor expressed on murine dendritic cells in vivo
by: McKenzie, E, et al.
Published: (2005)

The toll-like receptor-nuclear factor kappaB pathway in rheumatoid arthritis.
by: Andreakos, E, et al.
Published: (2005)

The cellular pathway of antigen presentation: biochemical and functional analysis of antigen processing in dendritic cells and macrophages.
by: Chain, B, et al.
Published: (1986)

Interleukin-4 inhibits kappa light chain expression and NF kappa B activation but not I kappa B alpha degradation in 70Z/3 murine pre-B cells.
by: Clarke, C, et al.
Published: (1995)

Alveolar macrophages and T cells from sarcoid, but not normal lung, are permissive to adenovirus infection and allow analysis of NF-kappa b-dependent signaling pathways.
by: Conron, M, et al.
Published: (2001)

NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts.
by: Smith, C, et al.
Published: (2001)

Adenoviral gene transfer of the endogenous inhibitor IkappaBalpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependent.
by: Bondeson, J, et al.
Published: (2007)

Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.
by: Sachamitr, P, et al.
Published: (2012)

Antigen-presenting cells. Experimental and clinical studies of dendritic cells.
by: Austyn, J
Published: (2000)

Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NFkappaB in tumour necrosis factor production.
by: Foxwell, B, et al.
Published: (2000)

CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens.
by: Salio, M, et al.
Published: (2004)

Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo.
by: Shakhar, G, et al.
Published: (2005)

Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (2002)

TNFalpha-induced macrophage chemokine secretion is more dependent on NF-kappaB expression than lipopolysaccharides-induced macrophage chemokine secretion.
by: Ciesielski, C, et al.
Published: (2002)

IκB kinase 2 but not NF-κB-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction
by: Andreakos, E, et al.
Published: (2003)

The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro.
by: Sala, K, et al.
Published: (2015)

Thymoquinone inhibits murine leukemia WEHI-3 cells in vivo and in vitro
by: Salim, L.Z.A., et al.
Published: (2014)

Analysis of the murine 5-HT receptor gene promoter in vitro and in vivo.
by: Ansorge, M, et al.
Published: (2004)

Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant.
by: Andreakos, E, et al.
Published: (2006)

VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2.
by: Kiriakidis, S, et al.
Published: (2003)

VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2.
by: Kiriakidis, S, et al.
Published: (2003)

Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis.
by: Monaco, C, et al.
Published: (2004)

The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?
by: Feldmann, M, et al.
Published: (1999)

Human T cell clones present antigen.
by: Hewitt, C, et al.
Published: (1989)

Dendritic cell-expressed common gamma-chain recruits IL-15 for trans-presentation at the murine immunological synapse
by: Beilin, C, et al.
Published: (2017)

Tracking antigen-experienced effector T cells in vitro and in vivo.
by: Gorman, C, et al.
Published: (2010)

Cytokines and anti-cytokine biologicals in autoimmunity: present and future.
by: Andreakos, E, et al.
Published: (2002)

Rac mediates TNF-induced cytokine production via modulation of NF-kappaB.
by: Williams, L, et al.
Published: (2008)

Murine CD8 T‐cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density
by: Gilfillan, Connie B., et al.
Published: (2020)

Murine cd4+ T cell Responses are inhibited by cytotoxic T cell-mediated killing of dendritic cells and are restored by antigen transfer
by: Ma, Joel Zhi-Iong, et al.
Published: (2013)